https://www.orenitramhcp.com/ https://www.orenitramhcp.com/media/content/images/ore-logo-dark.svg https://www.orenitramhcp.com/patient-cost-assistance/specialty-pharmacy https://www.orenitramhcp.com/media/content/images/iassist-video-thumbnail@2x.webp iAssist: Simplify the Process of Getting Patients Started With just a few clicks, your office can leverage the iAssist platform, which may minimize delays in therapy initiation for your patients. https://player.vimeo.com/video/680135392?h=973adda3d3 https://www.orenitramhcp.com/starting-patients/90-day-trial-program https://www.orenitramhcp.com/media/content/images/orenitram-90-day-trial.svg https://www.orenitramhcp.com/freedom-ev https://www.orenitramhcp.com/media/content/images/clinical-worsening-events.svg https://www.orenitramhcp.com/media/content/images/nt-probnp-change-from-baseline@2x.png https://www.orenitramhcp.com/media/content/images/efficacy-4-strata-risk-status-improvement@2x.png https://www.orenitramhcp.com/media/content/images/freedom-ev-video.png FREEDOM-EV video Hear from the principal investigator of FREEDOM-EV, R. James White, MD, PhD, who discusses the trial’s key patient characteristics and important outcomes. https://www.youtube.com/watch?v=kq-qtQLfBvA https://www.orenitramhcp.com/media/content/images/measuring-risk-in-pah.png Measuring Risk and the Impact of Orenitram See the effect that Orenitram had on several key risk parameters—as well as overall risk status—in FREEDOM-EV with Jean Elwing, MD. https://www.youtube.com/watch?v=1lfd6WhkwCQ https://www.orenitramhcp.com/transition https://www.orenitramhcp.com/media/content/images/annotated-rem-ore-transition.svg https://www.orenitramhcp.com/patient-cost-assistance https://www.orenitramhcp.com/media/content/images/myorenitram-thumnail.png MyOrenitram HCP Preview Video Overview video explaining the Orenitram Co-Pay Assistance Program, 90-Day Trial, and ASSIST support options for eligible patients. https://www.youtube.com/watch?v=G_cd4BD8P1Y https://www.orenitramhcp.com/pah-disease-progression https://www.orenitramhcp.com/media/content/images/4-strata-earlier-identification.svg https://www.orenitramhcp.com/starting-patients/managing-adverse-events https://www.orenitramhcp.com/media/content/images/managing-dosing-video.png Orenitram dosing and AE management as a team video Franck Rahaghi, MD, and Starlet Harrimon, RN, discuss how they work with patients to plan for expected adverse effects with Orenitram. https://www.youtube.com/watch?v=smFMInl-A1E&t=1s https://www.orenitramhcp.com/media/content/images/tables/proactive-approaches.svg https://www.orenitramhcp.com/dosing-orenitram/titration-kit https://www.orenitramhcp.com/media/content/images/meet-ore-TK.png Orenitram Titration Kit Video Learn more about the Orenitram Titration Kit, an all-in-one kit designed for a simplified and confident start on Orenitram https://www.youtube.com/watch?v=Xdll0cuG5DE https://www.orenitramhcp.com/media/content/images/titrationKit-image.png https://www.orenitramhcp.com/media/content/images/orenitram-titration-kit-monthly@2x.webp https://www.orenitramhcp.com/media/content/images/orenitram-titration-kit-weekly@2x.webp https://www.orenitramhcp.com/media/content/images/orenitram-titration-kit-daily@2x.webp https://www.orenitramhcp.com/media/content/images/TK-patient-guide.png https://www.orenitramhcp.com/pah-disease-progression/moderate-rv-dysfunction https://www.orenitramhcp.com/media/content/images/moderate-rv-changes-occur.svg https://www.orenitramhcp.com/media/content/images/rv-guideline-echo.png https://www.orenitramhcp.com/site-map https://www.orenitramhcp.com/why-orenitram/moderate-pah-profiles https://www.orenitramhcp.com/why-orenitram https://www.orenitramhcp.com/media/content/images/intermediate-risk-video-thumbnail.png Why Orenitram To learn more about how Orenitram may help your intermediate-risk patients, watch the video. https://www.youtube.com/watch?v=-qM-1KO35ws https://www.orenitramhcp.com/media/content/images/consider-orenitram-table.png https://www.orenitramhcp.com/dosing-orenitram https://www.orenitramhcp.com/media/content/images/flexible-dosing-thumbnail.png Dosing Flexibility Learn how flexible dosing with Orenitram helps to address the evolving needs of intermediate risk PAH patients. https://www.youtube.com/watch?v=tA6USg1k9iE&t=1s https://www.orenitramhcp.com/media/content/images/managing-dosing-video.png Dosing and AE Management as a Team Listen to Franck Rahaghi, MD, and Starlet Harrimon, RN, as they discuss how risk assessment measures and planning for expected adverse effects can help guide treatment with Orenitram. https://www.youtube.com/watch?v=smFMInl-A1E&t=1s https://www.orenitramhcp.com/media/content/images/orenitram-titration-kit-weekly@2x.webp https://www.orenitramhcp.com/patient-cost-assistance/video-and-resource-library https://www.orenitramhcp.com/media/content/images/right-heart-function-video.png Right Heart Function in FREEDOM-EV Learn about the impact of Orenitram on right heart function in the FREEDOM-EV trial from Paul Forfia, MD. https://www.youtube.com/watch?v=2k3gts-R10E https://www.orenitramhcp.com/media/content/images/measuring-risk-in-pah.png Measuring Risk and the Impact of Orenitram See the effect that Orenitram had on several key risk parameters—as well as overall risk status—in FREEDOM-EV with Jean Elwing, MD. https://www.youtube.com/watch?v=1lfd6WhkwCQ https://www.orenitramhcp.com/media/content/images/intermediate-risk-video-thumbnail.png Why Orenitram? Video Discover how Orenitram provides clinical intervention for when patients need improvement in key measures of risk. https://www.youtube.com/watch?v=-qM-1KO35ws https://www.orenitramhcp.com/media/content/images/flexible-dosing-thumbnail.png Dosing Flexibility Learn how flexible dosing with Orenitram helps to address the evolving needs of intermediate risk PAH patients. https://www.youtube.com/watch?v=tA6USg1k9iE&t=1s https://www.orenitramhcp.com/media/content/images/meet-ore-TK.png Orenitram Titration Kit See how the Orenitram Titration Kit may guide your patient through the first 3 months of their treatment journey. https://www.youtube.com/watch?v=Xdll0cuG5DE https://www.orenitramhcp.com/media/content/images/freedom-ev-video.png Discussion of FREEDOM-EV Trial Hear the principal investigator of FREEDOM-EV, R. James White, MD, PhD, discuss the trial’s background and important outcomes. https://www.youtube.com/watch?v=kq-qtQLfBvA https://www.orenitramhcp.com/media/content/images/managing-dosing-video.png Dosing and AE Management as a Team Listen to Franck Rahaghi, MD, and Starlet Harrimon, RN, as they discuss how risk assessment measures and planning for expected adverse effects can help guide treatment with Orenitram. https://www.youtube.com/watch?v=smFMInl-A1E&t=1s https://www.orenitramhcp.com/starting-patients https://www.orenitramhcp.com/why-orenitram/mechanism-of-action https://www.orenitramhcp.com/media/content/images/prostacyclin-synthase-expression-mobile@2x.webp https://www.orenitramhcp.com/media/content/images/treprostinil-multiple-receptors.svg https://www.orenitramhcp.com/media/content/images/oral-prostacyclin-mechanism-of-action@2x.webp https://www.orenitramhcp.com/why-orenitram/adverse-events